Immuneering Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	320	425	68	215	128	426
Market Cap Growth	610.51%	522.72%	-68.25%	67.91%	-69.89%	-
Enterprise Value	121.46	255.98	35.99	133.64	27.07	281.49
Last Close Price	4.94	6.58	2.20	7.35	4.85	16.17
PS Ratio	-	-	-	-	404.26	204.62
PB Ratio	1.53	1.95	1.65	2.38	1.17	2.73
P/TBV Ratio	1.23	1.33	1.59	2.31	1.17	1.41
EV/Sales Ratio	-	-	-	-	85.40	135.33
Debt / Equity Ratio	0.02	0.02	0.09	0.05	0.04	0.03
Net Debt / Equity Ratio	-0.74	-0.77	-0.77	-0.90	-0.92	-0.92
Net Debt / EBITDA Ratio	2.60	2.86	0.50	1.40	1.96	4.25
Net Debt / FCF Ratio	3.07	3.72	0.58	1.65	2.25	4.65
Asset Turnover	-	0	0	0	0.00	0.02
Quick Ratio	31.50	17.16	4.82	10.92	13.10	26.53
Current Ratio	32.45	17.50	5.28	11.35	13.50	27.04
Return on Equity (ROE)	-25.62%	-43.12%	-92.51%	-53.36%	-38.00%	-35.01%
Return on Assets (ROA)	-26.51%	-41.71%	-82.51%	-51.93%	-35.80%	-32.74%
Return on Invested Capital (ROIC)	-114.59%	-199.90%	-664.94%	-620.75%	-485.13%	-594.36%
Return on Capital Employed (ROCE)	-27.44%	-44.46%	-91.56%	-55.88%	-37.58%	-34.36%
Buyback Yield / Dilution	-105.22%	-46.80%	-5.51%	-7.69%	-93.84%	-175.00%
Total Shareholder Return	-105.22%	-46.80%	-5.51%	-7.69%	-93.84%	-175.00%

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q